Ovid Therapeutics Inc.OVIDNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank82
Studio
Year-over-Year Change

Return on equity

Latest
-13.33%
↑ 78% vs avg
Percentile
P82
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-61.35%
Historical baseline
PeriodValueYoY Change
2025-13.33%+65.6%
2024-38.74%+35.0%
2023-59.61%-45.6%
2022-40.95%-159.9%
202168.34%+136.8%
2020-185.73%-115.1%
2019-86.34%+35.5%
2018-133.95%-72.5%
2017-77.67%-70.8%
2016-45.47%-